Table 2 Associations between COX2 haplotypes and prostate cancer risk among Caucasiansa

From: COX2 genetic variation, NSAIDs, and advanced prostate cancer risk

rs689466

rs20417

rs2745557

rs5277

rs2066826

rs5275

Haplotype % in cases/controls

OR (95% CI)

A

G

A

C

G

A

16/20

1.00

G

G

G

C

G

A

19/18

1.29 (0.94–1.77)

A

G

G

C

G

G

17/16

1.30 (0.94–1.81)

A

G

G

G

G

A

19/15

1.56 (1.12–2.19)b

A

G

G

C

G

A

13/15

1.09 (0.78–1.53)

A

C

G

C

A

G

13/14

1.12 (0.79–1.59)

  1. Adjusted for age and institution.
  2. bP=0.009.
Back to article page